Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
出版年份 2016 全文链接
标题
Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
作者
关键词
Corticosteroid tapering, Prostate cancer, Androgen receptor
出版物
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 39, Issue 7, Pages 729-738
出版商
Springer Nature
发表日期
2016-01-20
DOI
10.1007/s40618-016-0430-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.
- (2017) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer
- (2017) Philip J. Saylor et al. Journal of the National Comprehensive Cancer Network
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular pathways and targets in prostate cancer
- (2015) Emma Shtivelman et al. Oncotarget
- PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
- (2014) AndrewC Hsieh et al. ASIAN JOURNAL OF ANDROLOGY
- Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis
- (2014) K. Esposito et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comment gérer l’arrêt d’une corticothérapie ?
- (2014) Jean-Marc Kuhn et al. PRESSE MEDICALE
- Tumor clone dynamics in lethal prostate cancer
- (2014) S. Carreira et al. Science Translational Medicine
- Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
- (2014) Masis Isikbay et al. Hormones & Cancer
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
- (2013) R. Ferraldeschi et al. CLINICAL CANCER RESEARCH
- Clinical evaluation and optimal management of cancer cachexia
- (2013) Albert Tuca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe
- (2013) Ashley Grossman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
- (2012) J. Richards et al. CANCER RESEARCH
- Reduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated rats
- (2012) Maitê M. Costa et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
- (2012) Norman T Ilowite et al. Pediatric Rheumatology
- Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models
- (2011) Giovanni Luca Gravina et al. ENDOCRINOLOGY
- Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
- (2011) Gerhardt Attard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
- (2009) M. P. Steinkamp et al. CANCER RESEARCH
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Timothy C. Ryken et al. JOURNAL OF NEURO-ONCOLOGY
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
- (2008) J. A. Locke et al. CANCER RESEARCH
- Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
- (2008) M.-L. Zhu et al. ENDOCRINE-RELATED CANCER
- Withdrawal from glucocorticosteroid therapy: clinical practice recommendations
- (2008) Crésio Alves et al. Jornal de Pediatria
- The use and toxicity of steroids in the management of patients with brain metastases
- (2008) Alina Sturdza et al. SUPPORTIVE CARE IN CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started